Once again, due to problems with the supplier, the product was unavailable through conventional pharmacies and the cost of a bottle of Miraflow (20 mL) skyrocketed from $6.00 to $30 on eBay -- an increase of 400%. This created a negative perception of a lack of affordability of CIBA's core products. CIBA took note of this problem and collaborated with I2, a supply chain company. It set the goal of keeping product availability at major retail establishments at 99.5%. Before embarking upon its venture with I2, the product supply chain was highly fragmented, resulting in shortages in many areas and causing the price to spike online. The result was a series of unhappy customers. This also had the effect of deterring new customers from trying CIBA Vision products, because of the perception of the product being unnecessarily pricy. Collaborating with a singular company allowed for a higher level of product availability -- up to the stated goal of 99.5%. Because of improved distribution and the absence of shortages, this reduced costs for consumers. Through greater optimization and monitoring of inventory, the timing new product...
This is another example of effective 'backward' vertical integration and gaining more effective control over the supply chain. In the future, to communicate better with customers, the company should also allow consumers to use the website to find out about the availability of CIBA Vision eye care products in their areas, so they can easily locate the nearest source (for example, they could be permitted to type in their zip codes and be directed to a 'product finder' that would allow them to find CIBA eye care products at the stores nearest to their homes).
Alcon must learn from such innovative stands, and incorporate these ideas into its own medical offerings in its surgical, pharmaceutical, and vision care products. By bringing the R&D components of all satellite organizations into one entity, it will be able to make use of some of the innovative thinking present at CIBA. However, it must be careful to ensure that this is genuinely a learning effort, and ensure that Alcon
Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense
Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now